PTGS2 and cancer: The results revealed that COX-2 gene silencing led to a near total loss of COX-2 expression, and compared with the untransfected and control siRNA groups and positive control β-actin, the expressions of COX-2 proteins in MKN45 and MKN74 cancer cells were significantly inhibited (Figure 3A).